Showing posts with label Biotechnology. Show all posts
Showing posts with label Biotechnology. Show all posts

Jan 17, 2025

Unlocking the Secrets of Medicinal Plant Biotechnology: A Deep Dive into Recent Advances

 


In the rapidly evolving field of plant biotechnology, researchers are harnessing advanced techniques to ensure the authenticity, quality, and enhanced production of valuable medicinal compounds. A recent talk on Biotechnological interventions for conservation, propagation, and improved therapeutic efficacy of medicinal plants from the Centre for Transgenic Plant Development illuminated groundbreaking work in plant authentication, metabolic engineering, and the innovative use of molecular tools such as SCAR markers and microRNAs. In this blog post, we'll explore these topics in detail, explain complex concepts in simple terms, and discuss their broader implications for health, sustainability, and the future of herbal medicine.

The talk was delivered by Professor M. Z. Abdin,
Director, Centre for Environment and Sustainable Development
Department of Biotechnology
School of Chemical and Life Sciences
Jamia Hamdard
Hamdard Nagar, New Delhi – 110062, India

Associate Professor J. Govinden Soulange, Dean of the Faculty of Agriculture gave Professor Abdin,  a token gift in recognition of his contributions as an external examiner and for delivering an inspiring talk at the Faculty of Agriculture.


Ensuring Authenticity with SCAR Markers

The Challenge of Adulteration in Herbal Products

Herbal products have been used for centuries, but with their growing popularity worldwide, a major issue has arisen: adulteration. Adulteration refers to the deliberate or accidental mixing of a plant with other species, which can compromise the product’s effectiveness and safety. Plants that look similar or share names are often mixed up, leading to mislabeling and loss of trust among consumers.

Why Authenticity Matters:

  • Safety: Adulterated products can introduce unknown compounds that may be harmful.
  • Efficacy: The therapeutic effects of a herbal remedy rely on the correct plant species being present.
  • Regulation: Ensuring authenticity helps regulatory agencies maintain standards and protect public health.

How SCAR Markers Work

SCAR (Sequence Characterized Amplified Region) markers are DNA-based tools developed to verify the identity of plant species with high precision. Let’s explore the step-by-step process that scientists use to create and apply these markers:

  1. Discovery Phase:
    • Researchers begin with RAPD-PCR (Random Amplified Polymorphic DNA Polymerase Chain Reaction). They use random primers to amplify many segments of DNA from both the target plant (e.g., Ruta graveolens) and potential adulterant species.
    • The results are visualized on a gel, revealing bands—distinct lengths of DNA fragments. Each band corresponds to a specific sequence piece.
  2. Identifying Unique DNA Fragments:
    • By comparing the patterns of bands from different plants, scientists look for a fragment that appears only in the genuine plant. In our case, a unique 670 base pair (bp) band was found in Ruta graveolens but not in the adulterant.
    • This fragment serves as a molecular fingerprint—a characteristic piece of DNA that sets the genuine plant apart.
  3. Developing Specific Markers:
    • The unique 670 bp fragment is excised from the gel and its sequence is determined.
    • Based on this sequence, scientists design specific SCAR primers. These primers are like highly specialized "keys" that unlock only the DNA from the genuine plant.
    • When these primers are used in a PCR reaction with DNA from a sample, they will only produce a visible band if the sample contains the target DNA.
  4. Application in Authenticity Testing:
    • Quality control labs can extract DNA from herbal products and use SCAR primers to test for the presence of the authentic plant.
    • A positive result—a band of the expected size on a gel—confirms that the product contains the genuine Ruta graveolens. The absence of the band suggests possible adulteration or substitution.

Real-World Impact of SCAR Markers

The development of SCAR markers has far-reaching implications:

  • Consumer Confidence: Buyers can trust that the herbal products they purchase contain the ingredients advertised.
  • Regulatory Compliance: Manufacturers can certify their products with a molecular “seal of authenticity,” reducing the risk of legal issues and product recalls.
  • Conservation Efforts: Identifying authentic plant materials helps in the conservation of rare species by preventing their exploitation under false pretenses.

Metabolic Engineering: Boosting Artemisinin Production

The Global Significance of Artemisinin

Malaria remains a major global health issue, particularly in tropical regions. Artemisinin, derived from the plant Artemisia annua, is a cornerstone of modern antimalarial therapy. However, the naturally low concentration of artemisinin in the plant poses challenges:

  • Supply Limitations: Low yield means more land and resources are needed to produce sufficient quantities.
  • Cost: Extracting artemisinin from plants is expensive, impacting the affordability of lifesaving treatments.

To address these challenges, scientists are using metabolic engineering to increase artemisinin production within the plant itself.

Strategies for Enhancing Artemisinin Yield

  1. Overexpressing Key Enzymes:
    • Enzymes like HMG-CoA reductase and amorpha-4,11-diene synthase play crucial roles in the pathway leading to artemisinin synthesis.
    • By introducing extra copies of the genes encoding these enzymes under strong promoters, researchers can significantly boost their production.
    • This approach nearly doubled the artemisinin content from 0.65% to 1.25%, but further increases were sought without harming the plant.
  2. Advanced Approach: Targeting Enzymes to Chloroplasts
    • Why Chloroplasts?
      Chloroplasts are compartments within plant cells primarily responsible for photosynthesis. They have a distinct environment and resources that can be advantageous for producing certain compounds.
    • The Strategy:
      • Some enzymes in the artemisinin biosynthetic pathway were engineered with special signal sequences directing them to the chloroplast instead of staying in the cytoplasm.
      • This re-routing is a form of compartmentalization—isolating part of the pathway in a dedicated space to enhance efficiency.
    • Benefits:
      • Optimized Conditions: Chloroplasts may provide more of the necessary precursors, energy, and a favorable environment for these enzymes.
      • Minimized Interference: Keeping the artemisinin pathway separate from other cellular processes reduces competition for resources and avoids potential harmful interactions.
      • Higher Yields, Healthier Plants: Compartmentalization allowed plants to produce around 2.69% artemisinin without negatively affecting growth or other functions.
    • Analogy:
      Think of a busy factory that needs to ramp up production of a complex product without disturbing other operations. By setting up a specialized, isolated assembly line (the chloroplast), the factory can focus on making more of that product efficiently, while the rest of the factory continues its regular work undisturbed.

Broader Implications for Global Health

Improving artemisinin production through metabolic engineering:

  • Lowers the cost of antimalarial drugs.
  • Increases accessibility, especially in malaria-endemic regions.
  • Reduces dependence on variable agricultural yields, leading to a more consistent supply.

Harnessing microRNAs for Stevia Enhancement

Introduction to microRNAs (miRNAs)

microRNAs are tiny RNA molecules that regulate gene expression—essentially controlling how much of a protein a gene produces. They bind to messenger RNAs (mRNAs) and either block their translation into proteins or mark them for destruction. Think of them as the factory supervisors that adjust production levels based on demand.

microRNAs in Action in Stevia

Researchers have applied knowledge of miRNAs to improve Stevia rebaudiana, the plant that produces natural sweeteners called steviol glycosides. Two particular miRNAs,  MiR319g and miRSTv_11, were of special interest:

  • MiR319g:
    When scientists increased the levels of MiR319g in Stevia, it reduced the production of enzymes involved in making the sweet compounds. As a result, levels of stevioside and rebaudioside A decreased.
  • miRSTv_11:
    Surprisingly, raising the levels of miRSTv_11 had the opposite effect. Rather than shutting down production, miRSTv_11 bound to promoter regions of target genes (regions of DNA that initiate gene transcription) and actually enhanced their expression. This led to increased levels of the sweet compounds.

How Were These miRNAs Used?

  1. Identification and Prediction:
    • Scientists extracted small RNAs from Stevia plants and sequenced them to identify different miRNAs.
    • Using computational tools, they predicted which genes these miRNAs would target—particularly those involved in the pathway that produces sweet compounds.
  2. Manipulation Techniques:
    • Overexpression:
      By inserting additional copies of the miRNA genes into the plant, researchers could increase the levels of specific miRNAs like miRSTv_11
    • Downregulation:
      Techniques to reduce certain miRNAs’ levels allowed researchers to observe decreases in sweet compound production, confirming the miRNA’s role.
  3. Outcomes in Stevia:
    • With higher miRSTv_11 levels, the plant produced more rebaudioside A, a sweeter and less bitter compound compared to stevioside.
    • This makes Stevia-based sweeteners more palatable and potentially healthier for consumers.

Why This is Important

  • Consumer Health:
    Enhanced Stevia products can provide a natural, zero-calorie sweetener that tastes better and may offer additional health benefits, especially for those managing conditions like diabetes.
  • Agricultural Impact:
    Improved Stevia varieties can lead to more efficient production, benefiting farmers and reducing costs.
  • Scientific Breakthrough:
    The discovery that a microRNA can act to enhance gene expression (as miRSTv_11 does) challenges traditional views of miRNAs solely as silencers. This opens new avenues for research and biotechnological applications.

Tissue Culture: The Foundation of Plant Biotechnology

Behind all these molecular innovations lies the fundamental technique of tissue culture. Tissue culture involves growing plant cells, tissues, or organs in sterile, controlled environments, providing a reliable platform for research and genetic modification.

Key Roles of Tissue Culture:

  • Propagation:
    It allows for the mass production of genetically identical plants, ensuring a consistent supply of high-quality plant material.
  • Conservation:
    Endangered or rare species can be preserved and multiplied without depleting wild populations.
  • Genetic Engineering:
    Tissue culture provides the setting where new genes, such as those for increased microRNA production or modified enzymes, can be introduced and the resulting changes observed.

Examples from the Research:

  • Stevia Propagation:
    Tissue culture techniques ensure a steady supply of Stevia rebaudiana, enabling repeated experiments and large-scale production.
  • Supporting Genetic Modifications:
    Plants like Artemisia annua and Withania somnifera (Ashwagandha) were cultured in vitro to apply genetic engineering methods such as inserting new genes or altering metabolic pathways.



 Why These Advances Matter

The integration of SCAR markers, metabolic engineering, and microRNA manipulation is more than a scientific achievement—it's a beacon of hope for addressing real-world challenges:

  • Quality Control:
    Ensuring authenticity of herbal products safeguards consumer health and maintains trust in natural remedies.
  • Increased Production:
    Boosting the yield of valuable compounds like artemisinin can save lives by making treatments more affordable and accessible.
  • Improved Products:
    Enhancing the sweetness and quality of natural sweeteners like Stevia can provide healthier alternatives to sugar and synthetic sweeteners.
  • Sustainability:
    Tissue culture and precision breeding reduce the strain on wild plant populations, aiding conservation efforts and promoting sustainable agriculture.
  • Scientific Innovation:
    Discoveries such as the unique function of miRSTv_11 expand our understanding of molecular biology, opening the door to new technologies and therapies.

 Conclusion

The insights shared in the talk from the Centre for Transgenic Plant Development underscore a transformative era in plant biotechnology. By combining traditional knowledge with modern molecular tools, scientists are improving the authenticity, efficiency, and quality of medicinal plants. These advancements not only promise better healthcare and sustainable solutions but also pave the way for future innovations that could revolutionize how we interact with the natural world and its therapeutic bounty.


Jan 29, 2017

Workshop on Creation of an institute of biotechnology in Mauritius



 
24 January 2017: A workshop to discuss the setting up of a National Biotechnology Institute, an initiative of the Ministry of Agro-Industry and Food Security, kicked off this morning at the Labourdonnais Waterfront Hotel, Port Louis.
 
Present at the opening ceremony, the Minister of Agro-Industry and Food Security, Mr Mahen Seeruttun, stated that the country is now ready to transform itself into a high-income economy and innovation has been recognized, as the key driver of economic growth in terms of wealth generation and job creation. Biotechnology is one of the vehicles of innovation that could contribute positively towards this vision, he added.
 
According to him, Mauritius has so far been timidly involved in biotechnology and very few institutions are engaged in this sector. The Mauritius Sugar Industry Research Institute under the aegis of the Mauritius Cane Industry Authority, Food and Agricultural Research and Extension Institute and the University of Mauritius are the few institutions that address biotechnology in their research and development programme, recalled Mr Seeruttun.
 
Consequently we have not been able to tap the full extent of this technology, he stressed, adding that his Ministry is committed to redress this situation. In this context, the National Biosafety Committee was reconstituted in March 2015. This committee is an advisory committee set up to advise on all aspects concerning the importation, exportation, transit, development, research, production, use, application, marketing, sale and the release of Genetically Modified Organisms (GMOs) or on any other matter concerning GMOs.
 
Actions to review the GMO Act 2004, which was only partially proclaimed in 2004, have been initiated stated the Minister and a revised draft of the GMO Act is already available. Moreover, the associated regulations to accompany this law are being finalised, he added. For Mr Seeruttun, all these initiatives will assist to protect human, animal and environmental health, protect consumers in making their choice regarding GMOs, and maintain an international quality and safety standards that facilitate trade.
 
Furthermore, the Minister announced that provision is being made for the setting of the National Biosafety Office in his Ministry to deal with administrative matters pertaining to Biosafety, GMOs and to cater for the enforcement of the law.
 
Application of biotechnology will be critical to help Mauritius meet the new challenges facing us such as climate change, new pests and diseases outbreaks and growing demands for food, feed, fibre and biofuels in the years to come, he said.
 
Government Information Service, Prime Minister’s Office, Level 6, New Government Centre, Port Louis, Mauritius. Email: gis@govmu.org  Website:http://gis.govmu.org

The speech of the Minster is reproduced below.


I am delighted to be present amongst you for the opening of a very important workshop on the setting up of The Mauritius Biotechnology Institute.

Biotechnology has a very broad meaning currently, ranging from basic research in medical and pharmaceutical fields, to environmental science, agriculture and food production.

It is unconceivable today to think of a world without biotechnology.

It has become an indispensable tool in our daily life, it is all around us and is influencing our lives, providing breakthrough products and technologies to combat diseases, reducing the environmental footprint and feeding the hungry.

Today, there are more than 250 biotechnology health care products and vaccines available to patients, many for previously untreatable diseases.

More than 13.3 million farmers around the world use agricultural biotechnology to increase crop yields, prevent damage from insects and pests and reduce farming’s impact on the environment.

While biotechnology is an opportunity to be seized for technological innovation, we must also be aware that the science of biotechnology should not operate in a vacuum.

It requires a structured approach with well-trained technical and scientific personnel and investments as well as appropriate legal framework.
We should admit that Mauritius, so far, has been timidly involved in biotechnology.

This is exemplified by the very few institutions involved in biotechnology. For example:

We have only a few tissue culture laboratories producing tissue cultured plantlets,
We also have a few testing laboratories and a few private companies offering molecular diagnostic tests,
There is only one institution dealing with plant molecular breeding and genetic mapping.

The MSIRI under the aegis of the Mauritius Cane Industry Authority, FAREI and the University of Mauritius are the few institution that address biotechnology in their research and development programme.

Consequently we have not been able to tap the full extent of this technology.

This “état de lieu” is partly explained by the present lack of human resources strategic facilities for research and development, and innovation and regulatory bodies.

My Ministry is committed to redress this situation.

As you may be aware, I have reconstituted the National Biosafety Committee in March 2015.

This committee is an advisory committee set up to advise on all aspects concerning the importation, exportation, transit, development, research, production, use, application, marketing, sale and the release of Genetically Modified Organisms (“GMOs”) or on any other matter concerning GMOs.

Furthermore, I have already initiated actions to review the GMO Act 2004, which was only partially proclaimed in 2004.

I understand that a revised draft of the GMO Act is already available.

The associated regulations to accompany this law are being finalised.

All these initiatives will assist to protect human, animal and environmental health, protect consumers in making their choice regarding GMOs, and maintain an international quality and safety standards that facilitate trade.

This year, I am paving the way so that the GMO Act be fully proclaimed for it to play its regulatory functions.

I am also making provision for the setting of the National Biosafety Office in my Ministry to deal with the administrative matters pertaining to Biosafety, GMOs and to cater for the enforcement of the law.

Mauritius has achieved remarkable economic success over the years.

The country is now ready to transform itself into a high-income economy.

Innovation has been recognized, as the key driver of economic growth in terms of wealth generation and job creation and Biotechnology is one of the vehicles of innovation that could contribute positively towards this vision.

Government firmly believes that Biotechnology can make significant contributions to our national priorities particularly in the area of human health, environment, agro-industry and the agricultural sector.

Application of biotechnology will be critical to help Mauritius meet the new challenges facing us such as climate change, new pests and diseases outbreaks and growing demands for food, feed, fibre and biofuels in the years to come.

Today Brazil, is a clear example of what can be achieved with a full application of biotechnology.

Brazil has indeed made significant progress in applying biotechnology through high investment in the training of its local scientists abroad and presently Brazil is one of the leaders in biotechnology amongst developing countries.

Brazil has now the capacity to address its local problems and it is recognised as one of the biggest energy producer from renewable energy to have the biggest fleet using duel fuel vehicle using gasoline and ethanol.

And Brazil is also one of the leaders in agricultural production and technology.

In the region, South Africa is another good example where biotechnology has given several positive outcomes.

Mauritius has the potential to be a key player in the field of biotechnology in the region in the near future.

Already, the MSIRI has a well-defined R & D programme in biotechnology and the activities undertaken are comparable with similar sugar research institutes around the world.
It is imperative that similar initiatives are taken in the non-sugar crops, livestock and other sectors in Mauritius.

This will allow the country to respond to some of our major challenges such as food security, climate change, health, energy, environment and conservation.

Mauritius would also be in a position to tap in a first instance the potential of the regional market and African region for biotechnology products such as biopharmaceuticals and functional food among others.

You would recall that during the Budget speech 2016-2017, provision has been made to undertake a feasibility study for the setting up of a Mauritius Biotechnology Institute.

Indeed during the past decade, several reports have been prepared following the feasibility study for the setting up of a National Food and Agricultural Biotechnology Institute in 2002.

These reports have rightly demonstrated the urgency of the setting up of Biotechnology Institute.

They have also clearly spelt out that the setting-up of such an Institute needs to cater for both human and financial resources.

However, there have also been diverging views on the scope of biotechnology that this institute would cover.

From what I have gathered, some of us advocate that there should be a national institute gathering under one roof all fields of biotechnology including pharmaceutical, marine, industrial, and agricultural biotechnology.

In this context, it is rightly pointed that it might bring efficiency in the utilisation of resources including human, institutional and financial.

But, on the other hand, I have also been made to understand that bringing all these fields under one roof might yield practical difficulties, as each biotechnology field is specific and the requirements and needs can be very different.

I am sure that the debate on the scope could be long and prolific.

As I have mentioned, the application of biotechnology is vast.

It is not a single and simple discipline, but a series of specialised tools and technologies that would contribute to a range of scientific disciplines including physical, chemical and biological sciences.

The aim of the workshop today is thus to brainstorm and to come up with the most ideal and pragmatic mission for a biotechnology Institute for Mauritius.

I believe that one of the major outcomes of this workshop would help to determine the scope of the activities of a Biotechnology Institute and to define its priorities.

Oct 9, 2014

European Biotech Week - 6 -12 Oct 2014

Biotech week


Biotech is buzzing in Europe this week! Why?? Well, this week is the European Biotech Week! View more about that special week here: http://www.biotechweek.org/ and tell us what are your hopes and dreams, using biotech tools for a better Mauritius, a better Africa?

Contributor: Murielle Lai Chin Kon, BSc(Hons) Biotechnology, Year 3